Ignite Creation Date:
2024-05-06 @ 2:57 PM
Last Modification Date:
2024-10-26 @ 1:40 PM
Study NCT ID:
NCT04476446
Status:
COMPLETED
Last Update Posted:
2023-09-14
First Post:
2020-07-15
Brief Title:
An Expanded Access Protocol for Esketamine Treatment in Participants With Treatment Resistant Depression TRD Who do Not Have Other Treatment Alternatives
Sponsor:
Janssen-Cilag SA
Organization:
Janssen-Cilag SA
Organization Data
Organization:
Janssen-Cilag SA
Class:
INDUSTRY
Study ID:
CR108690
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Janssen-Cilag SA
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None